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Desmin, the muscle-speci®c intermediate ®lament protein is one of the earliest known myogenic markers both in heart
and in somites. We have previously shown that high levels of desmin expression in the skeletal cell line C2C12 are due to
a distal enhancer, which contains a muscle-speci®c factor-2 (MEF2) binding site, adjacent to an E box, the binding site of
the myogenic Helix-Loop-Helix (mHLH) regulators. We have further shown that MEF2C, a myocyte restricted member of
the MEF2 family and all four mHLH factors can bind to their corresponding sites and through a cooperation with a second
proximal E box can transactivate the desmin promoter. To study the signi®cance of these regulatory elements in vivo, we
have generated transgenic mice with desmin±lacZ reporters, intact or mutated at the MEF2 and E box of the enhancer.
We show that the cis-acting DNA sequences within the 1-kb 5* ¯anking region of the mouse desmin gene are suf®cient
to direct appropriate temporal transcription both in heart and in skeletal muscle during mouse embryogenesis. Mutation
at the MEF2 site completely suppressed transcription of the linked lacZ transgene in both developing heart and somites
of the embryos. Mutation of the E box only suppressed activation in skeletal muscle precursors (somites and limb buds)
but not in cardiac muscle. These data demonstrate that the MEF2 site is indispensable for the desmin enhancer function
both in heart and in skeletal muscle. In addition, MEF2 cooperation with the mHLH regulators is absolutely necessary for
proper transcriptional activity during embryonic skeletal muscle development. q 1996 Academic Press, Inc.
INTRODUCTION 1989; Li and Paulin, 1991; Li and Capetanaki, 1991, 1993).
In the mouse, desmin ®rst appears at 8.25 days postcoitus
(dpc) in the neuroectoderm, where it is transiently expressedDesmin, the muscle-speci®c intermediate ®lament pro-
with vimentin and keratin. It then appears in the hearttein, is encoded by a single gene (Capetanaki et al., 1984)
rudiment at 8.5 dpc before any other muscle-speci®c prod-which is expressed in all muscle types (for review see Laza-
uct and at 9 dpc, desmin can be detected in the myotomerides et al., 1982; Lazarides and Capetanaki, 1986). It is one
(Schaart et al., 1989). The precise role of this molecule dur-of the earliest known myogenic markers (Choi et al., 1990;
ing these early stages of muscle development is presentlyKaufman and Foster, 1988) and one of the ®rst muscle-spe-
unknown. In recent studies, using both antisense RNAci®c proteins to appear during mammalian embryonic de-
techniques (Li et al., 1994) and complete inactivation of thevelopment (Hill et al., 1986; Schaart et al., 1989; Furst et
desmin gene by homologous recombination (Weitzer et al.,al., 1989; Babai et al., 1990; Mayo et al., 1992). In contrast
1995), it was demonstrated that in the absence of desminto all known muscle-speci®c genes, desmin is expressed in
myogenesis is completely inhibited. The exact mechanismsatellite cells (Allen et al., 1991) and in replicating myo-
by which desmin modulates myogenesis remains to beblasts (Kaufman and Foster, 1988). On the other hand, in
found. In addition, the regulatory factors that control des-parallel with other muscle-speci®c genes, upon the onset
min expression during these early stages of mouse embry-of fusion the expression of desmin is upregulated severalfold
onic development also remain elusive.(Bennett et al., 1979; Gard and Lazarides, 1980) and this
Understanding some of the mechanisms responsible forinduction is controlled at the transcriptional level (Capeta-
activation of muscle-speci®c gene expression during differ-naki et al., 1984; Pieper et al., 1987; Olson and Capetanaki,
entiation of skeletal muscle has been possible through the
discovery of the MyoD family of regulatory factors (for re-
view see Olson, 1990, and Weintraub, 1991), which include1 To whom correspondence should be addressed.
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MyoD (Davis et al., 1987), myogenin (Wright et al., 1989; transcription from basal promoters (Braun et al., 1989; Li
and Paulin, 1993; Li and Capetanaki, 1994; Cheng et al.,Edmonson and Olson, 1989), Myf5 (Braun et al., 1989), and
MRF4 (Rhodes and Konieczny, 1989; Miner and Wold, 1990; 1993; Edmondson et al., 1992; Gossett et al., 1989; Nakat-
suji et al., 1992; Yu et al., 1992). It has also been shownBraun et al., 1990). Each of these factors form obligatory
heteropolymers with the ubiquitous HLH proteins E12 and that MEF2 participates in the regulation of the myogenic
HLH genes (Edmondson et al., 1992; Cheng et al., 1993; YeeE47, through the HLH domain, before binding to the con-
sensus E box (GANNTG) of the muscle-speci®c genes (Las- and Rigby, 1993). The majority of the known cardiac gene
control regions have MEF2 sites and in those cases studiedsar et al., 1989; Brennan et al., 1991; Lin et al., 1991). These
myogenic regulators are expressed only in skeletal muscle this site is essential for transcription in cardiac myocytes,
in vitro (Zhu et al., 1991; Bassel-Duby et al., 1992; Amacherand during embryogenesis are ®rst detected within the myo-
genic precursor cells in the myotomal compartment of the et al., 1993; Navankasattusas et al., 1992).
Initial studies on the mechanism by which the mousesomites and in the limb buds. Myf5 is the ®rst member of
the family to be expressed in the rostral somites at 8 dpc desmin gene is regulated during skeletal myogenesis re-
vealed numerous potential muscle-speci®c and nonspeci®c(Ott et al., 1991; Montarras et al., 1991). At 8.5 dpc myo-
genin RNA appears and only 2 days later, at 10.5 dpc, MyoD cis-acting elements that belong to both positive and nega-
tive control regions located in the ®rst 1000 nt of the up-mRNA is detected (Sassoon et al., 1993). MRF4 shows a
biphasic pattern appearing ®rst at 9 dpc until 10.5 dpc and stream region of this gene (Li and Capetanaki, 1991, 1993),
as has also been found for the human desmin gene (Li andreappearing at 15.5 dpc. The Myf5, myogenin, and MyoD
proteins can be detected only 1 day after the appearance of Paulin, 1991). The ®rst 85 bp upstream of the transcription
initiation site, which include an E box (E1), are suf®cientthe respective RNAs (Smith et al., 1994).
In addition to the MyoD family, another transcription to confer low but muscle-speci®c expression of the desmin
gene in vitro. The maximal level of expression is achievedfactor important in muscle differentiation is MEF2, the my-
ocyte enhancer binding factor 2 (Cserjesi and Olson, 1991; in the presence of a region between 0578 and 0976 which
contains an E box (E2) and a MEF2 site and behaves asGosset et al., 1989), member of a new family of MADS
box transcription factors (For review see Olson et al., 1995; a classical enhancer (Li and Capetanaki, 1993). We have
previously shown that both myoD and myogenin can bindPollock and Treisman, 1991; Martin et al., 1993; Yu et al.,
1992). MEF2 was originally identi®ed as a myocyte-speci®c to the proximal E1 and distal E2 boxes of the mouse desmin
promoter and enhancer, respectively, and cotransfectionDNA binding activity that recognizes a conserved A/T-rich
region associated with several muscle-speci®c genes (Gos- studies with MyoD, myogenin, MRF4, and Myf5 in 10T1/
2 cells demonstrated that all these factors can transactivatesett et al., 1989; Cserjesi and Olson, 1991). Several members
of the MEF2 family, muscle-speci®c and ubiquitous, have desmin gene expression (Li and Capetanaki, 1993). We have
further analyzed this enhancer and demonstrated that thebeen identi®ed so far (Pollock and Treisman, 1991; Yu et
al., 1992; Chambers et al., 1992; Martin et al., 1993, 1994; myotube-speci®c MEF2C protein binds the desmin MEF2
site both in vitro and in vivo (Li and Capetanaki, 1994).McDermott et al., 1993; Leifer et al., 1993; Breitbart et al.,
1993). MEF2A, MEF2B, and MEF2D are expressed in a wide Furthermore, we have shown that the E2 box and the MEF2
site of the desmin enhancer can only function through coop-range of adult tissues (Pollock and Treisman, 1991; Yu et
al., 1992; Breitbart et al., 1993; Martin et al., 1994), while eration with the proximal E1 box (Li and Capetanaki, 1994).
To study the importance of these sites and their interactionsMEF2C expression is restricted to skeletal muscle, brain,
and spleen (McDermott et al., 1993; Martin et al., 1993). in vivo, we generated transgenic mice with mutations in
the MEF2 site and E2 box of the desmin enhancer and weMEFC is upregulated during myoblast differentiation and
can activate transcription of a reporter gene linked to multi- show here that this single MEF2 site controls desmin tran-
scription in both heart and skeletal muscle during mousecopies of the MCK desmin, MEF2 binding site (Martin et al.,
1993; Li and Capetanati, 1994). During mouse embryonic embryogenesis, while the E box seems to be important only
for expression in skeletal muscle during early development.development members of the MEF2 family seem to mark
both the cardiac and skeletal muscle lineages (Edmondson
et al., 1994). MEF2C seems to be one of the earliest markers
for the cardiac muscle lineage ®rst expressed at 7.5 dpc in MATERIAL AND METHODS
cells of the cardiac mesoderm. One day later, together with
MEF2A and MEF2D, it is detected in the myocardium. Construction of Desmin±lacZ Expression Vectors
MEF2C appears in the rostral myotomes only at Day 9 and
The 1.2-kb-long upstream fragment of the mouse desmin geneMEF2A and MEF2D appear later and are less muscle-spe-
used, containing 976-bp 5* ¯anking sequences and 200 bp of exonci®c. Later in development both MEF2A and MEF2C are
1, was isolated from the previously described desmin±CAT expres-
also expressed in smooth muscle (Edmondson et al., 1994). sion vector mD976 (Li and Capetanaki, 1993, 1994). This HindIII
The importance of the MEF2 site for muscle-speci®c tran- fragment was inserted at the MCS site of the nLacZ vector 46.21
scription has been demonstrated by mutations of this site (Fire et al., 1990), carrying a nuclear localization signal, after diges-
which impair transcription of muscle genes and by the ®nd- tion with HindIII/BamHI. This wild-type parental desmin±lacZ
vector (HX 46.21) was then used to generate the different desmin-ing that tandem copies of this site can direct muscle-speci®c
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described (Capetanaki et al., 1989a,b). ICR mice were used for these
experiments. Transgenic mice were identi®ed by Southern blot
analysis as previously described (Capetanaki et al., 1983). Four lines
carrying the wild-type transgene, 10 lines carrying the mutated
MEF2 site (mF2), 3 lines containing the mutated E2 site (mE2), and
3 lines mutated at both MEF2 and E2 sites (mE2F2) were analyzed.
Histochemical Staining for b-Galactosidase
Whole embryos were ®xed for 1 hr in 2% paraformaldehyde plus
0.2% glutaraldehyde in PBS and after washing thoroughly with PBS
they were stained for b-galactosidase in a PBS solution containing
5 mM X-gal, 5 mM potassium ferrocyanide, 5 mM potassium fer-
ricynide, and 2 mM MgCl2 at room temperature overnight. The
embryos were then rinsed twice with PBS containing 3% DMSO
and three times with 70% ethanol and stored in 70% ethanol until
they were photographed or embedded in paraf®n and sectioned for
histological counterstaining (Sanes et al., 1986; MacGregor et al.,FIG. 1. Expression vectors used for the generation of transgenic
1991).mice. The wild-type parental vector (WT) contains a HindIII±XbaI
fragment extending from 0976 to /200 bp relative to the desmin
transcription initiation site, inserted into the polylinker of the lacZ
vector pPD46.21. mF2, mE2, and mE2F2 vectors were generated by RESULTS
site-directed mutagenesis of the MEF2, E2, or both E2 and MEF2
sites, respectively, at the speci®c nucleotides as indicated. The Desmin 5* Flanking Region Directs Both
Skeletal and Cardiac Muscle-Speci®c Expression
of a Linked lacZ Reporter during
Mouse Embryogenesis
lacZ mutants on the E2 and MEF2 elements by simply replacing
In our initial efforts to de®ne the DNA sequences thatregions containing these elements with the corresponding mutated
regulate desmin transcription in vivo, we generatedsites from the mutant desmin CAT constructs described previously
(Li and Capetanaki, 1994). The original site-directed mutagenesis transgenic mice using the transgene HXCAT, which con-
within the desmin upstream sequences was performed as pre- tained the CAT reporter gene linked to 1 kb of the mouse
viously described (Kunkel et al., 1987). The 1-kb-long desmin up- desmin 5* ¯anking sequences which in vitro confer skeletal
stream fragment was excised from pmD976 CAT (Li and Capeta- muscle-speci®c expression (Li and Capetanaki, 1993, 1994).
naki, 1993) and subcloned in the HindIII/BamHI sites of the Analysis of several transgenic lines revealed that this region
M13mp18 vector. Oligonucleotides containing the mutated site(s), was suf®cient to drive expression in both cardiac and skele-
shown in Fig. 1, were used as primers with the M13 single-stranded
tal muscle (data not shown). Similar studies using the corre-DNA template for the synthesis of the mutated strand. The mu-
sponding human desmin 5* ¯anking region linked to a lacZtated fragments, which were initially subcloned back to desmin
reporter revealed that this region could confer only skeletalCAT constructs used in previously reported in vitro studies (Li
and not cardiac muscle expression (Li et al., 1993). To bothand Capetanaki, 1994), were subcloned into the parental wild-type
desmin±lacZ vector using the same strategy. address the observed difference between the mouse desmin±
CAT and the human desmin±lacZ expression patterns and,
most importantly, to analyze the temporal and spatial pat-
Generation of Transgenic Mice tern of desmin transcription during mouse embryonic mus-
cle development at the single cell level, we generated sev-For microinjections, a 4.6-kb fragment derived by digestion with
eral stable lines of transgenic mice harboring a nlacZ re-HindIII/NotI containing the 976 bp upstream plus the 200 bp of
porter linked to the mouse desmin 5* ¯anking regionexon 1 desmin sequences fused to the lacZ reporter was used. The
puri®ed DNA was used to generate transgenic mice as previously covering the area from /200 to 0976 (Fig. 1). Analysis of
FIG. 2. Developmental regulation of the desmin±lacZ transgene. Whole mount staining for lacZ activity of transgenic embryos, from
8.5±13.5 dpc, harboring the desmin±lacZ transgene. LacZ activity can be detected in the somites between 8 and 8.5 dpc. The rostrocaudal
gradient pattern of lacZ activity parallels the somite differentiation gradient during development. Transgene expression in heart is detected
earlier than 8.5 dpc; see Fig. 5.
FIG. 3. Desmin±lacZ transgene expression in all developing skeletal muscle ®bers of a 13.5-day-old embryo as detected by whole mount
staining. (A) Face, neck, and forelimb muscle are easily detected (original magni®cation 132). (B) Higher magni®cation (150) of a neck
triangle muscle from A. Notice the homogeneous multinuclear staining of the highly organized ®bers. (C) Developing muscle ®bers of
the trunk and fore and hind limbs (132).
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the lacZ activity by whole mount staining revealed expres- ventricle (Figs. 5B and 5G). Later in development the lacZ
activity is mainly pronounced in the right ventricle (Figs.sion of the transgene by 8.5 dpc both in the rostral somites
and in the developing heart (Fig. 2). This activation of the 5D and 5I). The expression in the left ventricle is much
weaker (Figs. 5C and 5H) and no detectable lacZ activity istransgene in the somites precedes protein detection by 1/2
a day (Schaart et al., 1989). By Day 9.5 the transgene is observed in the atrium (Figs. 5D and 5I). Our results contrast
with those obtained with the corresponding human 1-kb 5*strongly expressed within more than 21 somites and this
rostral-to-caudal progression of the lacZ activity continues ¯anking region, which does not confer cardiac expression
(Li et al., 1993).through development and parallels the normal pattern of
somite maturation and the expression of the myogenic HLH Immuno¯uorescence microscopy has shown that during
development desmin protein ®rst appears in the neuroec-transcription regulators (Cheng et al., 1993). Transverse sec-
tions through the somites revealed that the expression of toderm by 8.25 dpc, where it is transiently expressed to-
gether with vimentin and keratin (Schaart et al., 1989). LacZthe transgene is restricted in the myotome. By Days 10.75±
11.5 lacZ staining was detected in the mononucleated myo- activity was indeed detected in the neural fold and neural
groove at the level of the third hindbrain rhombomere, asgenic cells of the limb buds of the visceral arches and face
(Figs. 2±4). High levels of lacZ are subsequently expressed early as 8 dpc, as was the case with the human desmin±
lacZ transgene (Li et al., 1993). This activity seemed toin the newly forming skeletal muscle ®bers of the trunk,
limbs, neck, and head (Figs. 2 and 3). Analysis of transgenic persist longer than the endogenous desmin expression and
progressed caudally through the entire neural tube untilembryos between Days 10.5 and 11.5 of development re-
vealed that migrating myogenic progenitors in the zone of Day 10.5 pc, when the expression of the transgene began to
decline in the rostral region (Figs. 2, 4A, 4B, 5B, and 5D).migration between the somite myotome and limb bud do
express the desmin±lacZ transgene (Fig. 4), as was pre-
viously reported with similar studies using the correspond- Mutation of the Single MEF2 Site of the Desmining 5* ¯anking human desmin regulatory sequences (Li et
Enhancer Abolishes Desmin±lacZ Transgeneal., 1993). LacZ-positive cells migrating to the forelimb can
Transcription in Both Cardiac and Skeletalbe detected as early as 10.75 dpc and in the hindlimb at 11
Muscle during Normal Embryogenesisdpc (Figs. 4C and 4D). Interestingly, we observed that groups
of myogenic cells from neighboring somites at the level of Our in vitro studies during skeletal myogenesis have al-
lowed the identi®cation of a muscle enhancer the functionthe forelimb were migrating synchronously forming a front
of lacZ expressing cells even up to Day 11.25 of develop- of which depends on two regulatory elements, an E box (E)
and a MEF2 site (Fig. 1). To investigate the signi®cance ofment (see Fig. 4D). This happens at a time when regions of
lacZ-positive cells are also observed throughout the limb these elements in vivo, we mutated each site separately and
in combination by site-directed mutagenesis (Fig.1). Thesebud (Figs. 4B, 4D, and 4E).
mutated desmin±lacZ constructs were then used to gener-
ate several transgenic mice. Mutation of MEF2 in the
Desmin±LacZ Expression in the Developing Heart transgene (mF2) (Fig. 1) severely diminished lacZ expression
in both cardiac and skeletal muscle (Fig. 6). Ten indepen-Determination of cardiac muscle precursors in paired
mesocardial primordia occurs around Day 7.5 pc (Rugh, dent transgenic lines showed identical detrimental effects
on the expression of the transgene on both muscle types.1990). By Day 8 pc the positive heart rudiments fuse to a
single tubular heart where desmin expression is ®rst ob- The effect of the MEF2 mutation on the lacZ activity in
both the somites and the heart tube was profound as earlyserved (Babai et al., 1990; Hill et al., 1986; Mayo et al.,
1992; Shaart et al., 1989). Analysis of the lacZ activity in as 8.5 dpc (Fig. 7). Analysis of the MEF2 mutation on the
transgene expression later in development revealed that theall transgenic lines studied revealed that the wild-type
transgene can also be expressed at least as early as 8 dpc in MEF2 site controls transcription of the transgene in limb
buds as well as neck and face muscle (Fig. 6). The effect ofthe primitive cardiac tube (Figs. 5A and 5E). In some
strongly expressing lines this activity can be detected at the MEF2 mutation on the transgene expression both in
cardiac and skeletal muscle persisted throughout develop-stages between 7.5 and 7.75 dpc, that is, before the fusion
of the primitive heart rudiments (Figs. 5A and 5F). By Day ment (data not shown). In contrast to MEF2, as shown in
Fig. 7, mutation of the E2 box (mE2) alone caused complete8.5 pc in the newly formed common ventricle and atrium
the expression is stronger in the bulbus cordis and upper loss of lacZ expression in somites but not in the heart tube.
FIG. 4. Expression of desmin±lacZ transgene in myogenic progenitor cells migrating to the limb buds. Frontal sections through a hindlimb
(A, C) and a forelimb bud (B, D, E) of an 11-day-old mouse embryo. C and E are magni®cations (1200) of the areas corresponding to the
asterisk regions of A and B, respectively (140). D is a magni®cation (1200) of a region similar to the one shown by the arrow of B but
more posterior to it. Note how synchronously myogenic cells (m) migrate from neighboring somites to the limb buds. In E, it can be seen
that the majority of the migrated cells are still single myoblasts; h, heart; m, migrating myogenic cells; n, neural tube; s, somitic myotomes.
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Mutation of both the E2 box and MEF2 site (mE2F2) had the A Single MEF2 Site in the Desmin Enhancer
Controls Desmin Transcription duringsame severe inhibitory effect on the lacZ expression in both
somites and heart tube as shown with MEF2 alone. Embryogenesis Both in Skeletal Muscle
and in the Heart Ventricle
The present data show that the MEF2 site of the mouse
desmin enhancer is absolutely necessary for desmin geneDISCUSSION
transcription in all developing skeletal muscle precursors
and in the ventricle, but not the atrium of the heart. This1 kb of 5* Flanking Sequences of the Mouse Desmin
is the ®rst example of a muscle gene whose transcriptionGene Confers Both Cardiac and Skeletal Muscle
in vivo, in both heart and skeletal muscle, is tightly regu-Transcription during Mouse Embryogenesis
lated by a single MEF2 site. It is obvious from the present
study, however, that MEF2 is necessary but not suf®cientDesmin is encoded by a single gene which is expressed
in all muscle types. To begin to de®ne how the desmin for proper spatial expression in heart. The human desmin
1-kb 5* ¯anking region does contain a functional MEF2 siteregulatory elements can be differentially used to allow ex-
pression in different muscle types and at different stages but, except for a cluster of cells in the cardiac conductive
system, is not suf®cient to confer expression of theduring embryonic muscle development, we have analyzed
the expression of a lacZ reporter gene linked to intact and transgene in heart (Li et al., 1993). It is also not suf®cient
for expression in the atrium. Possibly, missing sequencesmutated desmin control regions in transgenic mice. Our
results show that the regulatory cis-acting elements in- located upstream of the 1-kb 5* ¯anking region, which were
not included in the transgene of the current study, maycluded within the 976 bp 5* of the transcription initiation
site confer appropriate temporal expression in skeletal and contribute to the observed differences. The same or addi-
tional sequences might also be responsible for the observedcardiac, but not smooth, muscle. It is of interest to note that
a very similar reporter transgene also containing around 1- differences in the level of expression between the right and
left ventricles. It has been recently shown that MEF2C iskb 5* ¯anking sequences can be activated in skeletal muscle
only (Li et al., 1993). At present we do not know the basis of the ®rst member of this family to be expressed in heart
primordia by 7.5 dpc and in somite by Day 9 pc (Edmondsonthis difference between the two genes. Comparison between
the two 5* ¯anking sequences revealed several diverging et al., 1994). By Day 8.5 MEF2A, MEF2C, and MEF2D
mRNAs are expressed in the myocardium of both the ven-regions whose importance is still unknown. For example,
at position 0538 of the mouse sequence there is a GATA tricle and the atrium. It is not yet known how ef®ciently
these mRNAs are translated in the two compartments. Con-consensus element which is absent in the human sequence.
This element is the binding site of a family of zinc ®nger sequently, we cannot assess if the observed differences in
desmin transgene expression between ventricle and atriumtranscription factors expressed in different tissues. One of
them, GATA-4, is expressed in atrial and ventricular cardio- are also due to corresponding differences in MEF2 protein
abundance and distribution. The present results, however,myocytes (Arececi et al., 1993). The signi®cance of this
element in the desmin expression in heart remains elusive. do suggest that transcriptional differences do exist between
ventricle and atrium, as well as between cardiomyocytes inPerhaps its lack in the human 1-kb region can explain ab-
sence of lacZ activity in the heart (Li et al., 1993). Other left and right compartments of the heart. The diversi®cation
of atrial and ventricular cardiomyogenic cell lineages duringelements, including the DNA binding sites (Chen and
Schwartz, 1995) of CSX/mkx-2.5 factor (Komuro and Izumo, early heart development has been previously suggested,
based on the chamber-speci®c gene expression pattern of1993; Lints et al., 1993), the vertebrate homologues of the
Drosophila tinman homeobox cardiac factor (Bodmer, some myosin heavy chain isoforms (Bisaha and Bader, 1991;
Yutzey et al., 1994; for review see Yutzey and Bader, 1995).1993), might be responsible for such differences as well.
This remains to be shown. Furthermore, transcriptional differences between cardio-
FIG. 5. Expression of the desmin±lacZ transgene during early heart development. (A) Whole mount staining of (a) a 7.5- to 7.75-day-old
embryo at left lower area indicated by long arrow and (b) an 8-day-old embryo. (B) An 8.5-day-old embryo. (C) Heart from a 10.5-day-old
embryo missing the right atrium which does not show any lacZ activity as is the case for the left one (la). (D) Transverse section of an
11.5-day-old embryo. (E) Section of the 8-day-old embryo from A through neural fold and cardiac tube. (F) Part of transverse section through
the cardiac primordia tubes before fusing, from the 7.5- to 7.75-day-old embryo shown by the arrow in A. (G) Transverse section through
the heart tube of the 8.5-day-old embryo in B. (H) Transverse sections through the heart of a 10.5-day-old embryo. Only the ventricles
are shown to compare with the one in I (a higher magni®cation of the heart area from D) from another desmin±lacZ transgenic line that
does not show much staining in the left ventricle. LacZ activity can be detected by Day 7.5 pc, even before the cardiac primordia tubes
fuse completely (A and F). The activity is localized in the myocardium of the ventricle but not the atrium from the very beginning. E, F
and G show frozen sections not counterstained; a, atrium; bc, bulbus cordis; ct, cardiac tube; la, left atrium; lv (LV), left ventricle; mc,
myocardium; ra ((RA), right atrium; rv (RV), right ventricle. Original magni®cations: A, B (140); C, D (150); E ±H (1200); I (1100).
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FIG. 6. Mutation of the MEF2 site diminishes desmin±lacZ transgene transcription both in heart and in skeletal muscle. Whole mount
staining of 9.5-, 10.5-, and 11.5-day-old (d) embryos harboring a wild-type (WT) or a mutated at the MEF2 site (mF2) desmin±lacZ transgene.
From the 10 different mF2 transgenic mouse lines analyzed the one shown here is the least dramatically affected. The nature of the
mutation is shown in Fig. 1.
FIG. 7. Mutation of the E2 site of the desmin enhancer is suf®cient to abolish desmin±lacZ expression in the somites but not the heart
tube during early mouse development. Whole mount staining of 8.5-day-old embryos with wild-type (WT) desmin±lacZ transgene or with
ones mutated at the MEF2 (mF2) site, at the E2 box (mE2) or both (mE2,F2). The expression vectors used are shown in Fig. 1 (original
magni®cation 140).
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myocytes in left and right compartments have recently been tor cells that migrate out from the ventrolateral part of the
adjacent somites (Chris et al., 1977). The present data con-suggested from studies with transgenic mice using the myo-
sin light chain 3F transgene (Kelly et al., 1995). Finally, we ®rm that these cells are committed to the myogenic fate
and do activate the mouse desmin±lacZ transgene, as hasalso believe that the absence of any lacZ activation in
smooth muscle might be due to the lack of smooth muscle- also been shown using the human desmin promoter (Li et
al., 1993). These cells, however, do not express detectablespeci®c or other elements from the 1-kb 5* ¯anking region
necessary for expression of the desmin gene in this tissue. levels of any of the mHLH factors at this stage (Sassoon et
al., 1993; Edmondson et al., 1994; Tajbakhsh and Bucking-
ham, 1994). Consequently, a major question now is what
The MEF2 Site Requires an Intact E2 Box for factors are responsible for the expression of desmin in the
Function of the Desmin Enhancer during cells migrating from scleromyotome to the limb buds? Since
Embryonic Skeletal Muscle Development mutation of the E box motif abolishes desmin expression
in the migrating muscle precursor cells, presumably a factorOur previous in vitro studies using C2C12 cells had shown
that the desmin enhancer can function ef®ciently, though not yet identi®ed, which recognizes this site, is required.
Pax3 is not an E box binding factor but is the only knownnot perfectly, in the absence of a functional distal E2 box,
by using its MEF2 site alone (see Fig. 1), always in coopera- regulator present in the migrating cells (Boder et al., 1994;
Goulding et al., 1994; Williams and Ordahl, 1994). It shouldtion with the proximal E1 box (Li and Capetanaki, 1994).
The present study showed that mutation of the E2 box re- be noted here that there is a potential Pax3 binding site at
the upstream regulatory region of the desmin gene, whoseduces signi®cantly the lacZ activity from the very early
stages of desmin expression (Fig. 6), thus demonstrating that signi®cance, however, remains elusive. The present results
suggest that if indeed Pax3 participates in the regulation ofin vivo MEF2 must synergize with the mHLH factors that
bind the distal E2 box for proper enhancer function. In addi- desmin, it must cooperate somehow with an E box binding
protein. A third question relates to desmin expression intion to the present in vivo and previous in vitro (Li and
Capetanaki, 1994) studies with the desmin gene , coopera- cells that have already migrated to the limb, that is, as early
as 10.75 dpc in the forelimb and 11.25 dpc in the hind limb.tion between MEF2 and mHLH factors has also been sug-
gested for the proper activation of the MRF4 promoter in In this case, the expression of the desmin enhancer could
be regulated by myf5, which is present at this time (Buck-vitro (Naidu et al., 1995), as well as for reporter genes con-
taining different combinations of multimerized MEF2 and ingham, 1994). MEF2, however, can be detected only 1 day
later, at 11.5 dpc (Edmondson et al., 1994). Consequently,E box sites (Kaushal et al., 1994; Molketin et al., 1995). In
the latter case it was further shown that this cooperation myf5 is the only known mHLH factor that could regulate
desmin expression in limb buds at these early stages.takes place through direct interaction between the basic
domain of the mHLH regulators and the MAD box of MEF2.
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